Variation in the detection, signaling, and repair of DNA damage contributes to human cancer risk. To assess capacity to modulate endogenous DNA damage among radiologic technologists who had been diagnosed with breast cancer and another malignancy (breast-other; n=42), early-onset breast cancer (early-onset, age ≤ 35; n=38), thyroid cancer (n=68), long-lived cancer-free individuals (hyper-normals; n=20) and cancer-free controls (n=49) we quantified DNA damage (single strand breaks and abasic sites) in untreated lymphoblastoid cell lines using the alkaline comet assay. Komet™ software provided comet tail length, % DNA in tail (tail DNA), comet distributed moment (CDM), and Olive tail moment (OTM) summarized as the geometric mean of 100 cells. Category cut-points (median and 75 th percentile) were determined from the distribution among controls. Tail length (for ≥ 75% vs. below the median, age adjusted) was most consistently associated with the highest odds ratios in the breast-other, early-onset, and thyroid cancer groups (with risk increased 10-, 5-or 19-fold, respectively, with wide confidence intervals) and decreased risk among the hyper-normal group. For the other three Comet measures, risk of breast-other was elevated approximately three-fold. Risk of early-onset breast cancer was mixed and risk of thyroid cancer ranged from null to a two-fold increase. The hyper-normal group showed decreased odds ratios for tail DNA and OTM, but not CDM. DNA damage, as estimated by all Comet measures, was relatively unaffected by survival time, reproductive factors, and prior radiation treatment. We detected a continuum of endogenous DNA damage that was highest among cancer cases, less in controls, and suggestively lowest in hyper-normal individuals. Measuring this DNA damage phenotype may contribute to the identification of susceptible sub-groups. Our observations require replication in a prospective study with a large number of pre-diagnostic samples. 3
Introduction
There is considerable evidence that individual variation in the detection, signaling, toleration, and repair of DNA damage (from internal and external exposures and intrinsic instability of DNA) contributes to human cancer risk (reviewed in [1] [2] [3] [4] [5] [6] ). Several studies (with sample sizes in excess of 20 cases and 20 controls) have reported increased breast [7, 8] and bladder [9] cancer risks associated with higher DNA damage measured by the comet assay [10] . In these studies elevated endogenous damage and post-mutagen challenge damage levels were associated with increased cancer risk. These results indicate that elevated endogenous damage is itself a risk factor, and are consistent with the notion that measures of endogenous damage are correlated with damage repair capability after an exogenous challenge.
We characterized risk of solid cancer associated with ability to limit DNA damage from endogenous DNA metabolic processes among persons with selected malignancies, compared to controls by quantifying single strand DNA breaks (SSB) and abasic sites of untreated cell lines using the alkaline comet assay. This assay provides a measure of the net effect of each cell's antioxidant and base excision repair pathway capacity to prevent and repair oxidative DNA damage, the major endogenous source of genomic instability [11] [12] [13] . In addition, we compared controls to individuals who were long-lived, cancer-free and reported no invasive cancer in first degree relatives. All the cases and controls were part of a larger, ongoing study of cancer and other health outcomes among radiologic technologists exposed through their occupation to low-dose radiation from medical sources.
Methods

Study population
In 1982, the U. S. National Cancer Institute, in collaboration with the University of Minnesota and the American Registry of Radiologic Technologists, initiated a study of cancer incidence and mortality among 146,022 U.S. radiologic technologists who were certified for at least two years between 1926 and 1982. The cohort members are predominantly female (73%) and their current mean age is 55 years [14] . The study has focused on cancers of the thyroid gland (papillary histology) and the female breast as these tissues are thought to be particularly radiation sensitive [15] .
Cancer confirmation and recruitment.
Cancer(s) reported on a study questionnaire were confirmed, and individuals were invited to provide a peripheral blood sample. At that time, for the rare persons with multiple cancers (including cancer of the breast and a second primary cancer), early-onset breast cancer (age 35 or younger) and papillary thyroid cancer, a portion of the sample was used to create EBV transformed lymphoblastoid cell lines. We sought to establish a lymphoblastoid cell line resource of approximately 40 to 60 individuals per cancer group. Approximately 50 cancer-free female controls were frequency matched on age (± 5 years) to the case groups. We also recruited 20 female radiologic technologists who were over 70 years of age, had never had any cancer (defined to include non-melanoma skin cancer), and had not reported any first degree relative with a cancer diagnosis at the time of blood collection. We referred to these individuals as "hyper-normal", akin to the naming convention used for similar selection strategies in related study designs [16] reasoning they may have a further decrease in background cancer risk compared to controls. All of the cases and controls provided informed consent and responded to a telephone interview that collected current cancer risk factors and family history of cancer. This study has been approved annually by the human subjects review boards of the National Cancer Institute and the University of Minnesota. Studies conducted at Lawrence Livermore National Laboratory (LLNL) have been approved annually by the LLNL Institutional Review Board.
Samples
A lymphoblastoid cell line was prepared by Epstein Barr virus transformation of peripheral blood lymphocytes obtained from each subject. All fresh samples were successfully transformed and each line was cryopreserved. For this study, the samples were tracked by a unique ID code, and investigators were blinded to case-control and case-group status. Cell lines were cultured in RPMI 1640 supplemented with 15% serum (Fetal Clone III, HyClone, Logan, Utah) and 2mM glutamine prior to analysis. Aliquots of all cell lines were cryopreserved at LLNL. The period of culture prior to analysis varied among cell lines, from about 3 to 5 weeks, depending on the growth rate of the cell line and the proportion of viable cells during early culture. For quality assessment, replicate samples of five individuals were included, some in the same shipment, others in separate shipments.
In addition, 16 cultures were repeated with personnel blinded to results of the first assay.
Measurement of DNA damage.
Cells were in exponential growth phase at the time of assessment of DNA damage.
Viability was determined by Trypan blue dye exclusion. The alkaline comet assay was used to measure DNA damage according to Singh et al. [10] with slight modifications. Frosted end glass microscope slides were first coated with 1.0% (w/v) agarose and allowed to dry. Cells were suspended in 0.5% low melting point agarose and spread on each of two slides with a coverslip.
After the agarose hardened, the coverslip was removed and slides were treated in the dark at 4°C
with lysis buffer (1% Triton X-100, 10% DMSO, 89% stock lysing solution: 2.8M NaCl, 0.1M Na 2 EDTA, 0.01M Trizma Base) at least overnight, then rinsed in 0.4 M Tris, pH 7.5. Slides were then placed in the electrophoresis unit and covered with a fresh solution of 300 mM NaOH, 1 mM EDTA, final pH >13.0, for 60 min. A split, balanced slide layout design was used (one slide from each sample was in each of two rows, but in different electrophoresis runs) to attend to position effects and run to run variation. The slides were electrophoresed at 0.92V/cm with current adjusted to 300 mamps for 25 min. The slides were washed in 0.4M Tris, pH 7.5, placed for 5 min. in cold methanol and allowed to dry. Each slide was stained with ethidium bromide (2 µg/ml) for 5 min.
Images of 50 cells on each of 2 slides were captured and comet parameters determined using 
Statistical analysis
We used the geometric mean of tail length, tail DNA, CDM and OTM of 100 randomly selected cells per subject as a summary measure to reduce the influence of outliers. We assessed normality of the subject-specific summary measures for each comet parameter and separately for value odds ratios when each factor was or was not included in the model. We found no meaningful change in the point estimates and therefore did not include any of these factors in the final model.
Because there were no male controls, we also analyzed the thyroid group excluding the male cases (n=9). We found no consequential alteration in the point estimates and report the odds ratios with men included. Tests for trend were adjusted for age and based on the underlying continuous variable. All significance tests were two sided and α was set at 0.05. The Statistical Package for the Social Sciences version 12.0 (SPSS, Inc., Chicago, Il) was used for all analyses.
The coefficient of variation (CV) was calculated separately for each comet parameter [17] among 5 blinded replicate and 16 blinded repeated samples. The CVs for tail DNA were 11.8% and 14.8%, for tail length were 7.6% and 12.4%, for CDM were 2.6% and 6.8%, for OTM were 11.6% and 18.9% among the 5 replicates and 16 repeats, respectively. These CV values are comparable to results from a recent study in which a lymphoblastoid line was assayed by alkaline comet for baseline damage in 16 batches of assays; a CV of 22% was observed [7] . For a radioimmunoassay commonly used for epidemiological studies, a CV of less than 15% is considered acceptable [18] .
Results
Individual comet results are presented in Table 1 , as are the results of the 5 blinded replicates and the 16 blinded repeats. In Table 2 (Table 2 ) except for tail length among those with thyroid cancer, however, the means did not differ by age group (P = 0.39). Similarly, comet parameters did not differ by the number of years between cancer diagnosis and blood collection (cases only), radiation treatment for cancer (cases only), and selected reproductive variables (data not shown). Tail length tended to marginally increase in most groups as the number of first degree relatives with breast cancer and the number of cancers within individuals increased (9 persons had three or more cancers, data not shown), but achieved only borderline statistical significance (P = 0.07). History of chemotherapy did not affect the means of the comet parameters, but the data obtained from medical records was incomplete (yes, n=13; no, n=16; unknown, n=118). The means and standard errors (parentheses) for tail length were 44.8 (1.7), 43.9 (2.8), and 45.0 (0.8) among those who did and did not have chemotherapy or their treatment status was not known, respectively (P = 0.88). We did not observe significant differences in comet parameters means for viability, sample shipment method, storage time, original laboratory, or calendar time over which the cells were scored.
Boxplots of the distributions of the geometric means of the comet parameters across 100 cells for each individual by case and control groups are shown in Figure 1 . All the parameters, except CDM, tended to be lower in the normal controls than the cancer case groups, with the hypernormal group having the lowest values of all the groups. Most comet parameters were highly correlated with each other (r 2 ≥ 0.49, P < 0.001). However, CDM was not correlated with tail length among the normal controls, the hyper-normal controls, and the breast and other cancer cases.
We present age-adjusted odds ratios (OR) and 95% confidence intervals (CI) for cancer risk in relationship to comet parameter categories in vs. below the median for the breast and other cancer, early-onset breast cancer, and thyroid cancer groups, respectively, with wide confidence intervals. Risk for early-onset breast cancer was inversely associated with tail DNA and CDM, and was not related to OTM. The hyper-normal controls were at or below the median of the normal controls for all comet parameters except CDM.
Discussion
We found a generally consistent association of increased endogenous DNA damage, or more specifically, a reduced capacity to limit endogenous damage, and increased cancer risk. This association was most strongly indicated by higher values of the comet parameter tail length. Risk of breast and other cancer and thyroid cancer also increased with increased tail DNA and OTM or only OTM, respectively. In addition, we found suggestive evidence in three of the four comet parameters evaluated that lower levels of DNA damage were associated with being long-lived, cancer-free, and without a history of cancer among first degree relatives, supporting the notion of a graded capacity to control endogenous DNA damage. We consider detecting evidence of such a continuum unique because hospital-or clinic-based studies seldom possess a well-characterized cohort from which to select individuals with defined characteristics, such as longevity and first degree relatives who are cancer-free. It is likely the hyper-normal individuals were also relatively free of co-morbidities, as they were able to visit their doctor or clinic with a study venipuncture kit and mail the kit successfully. This suggests the hyper-normal participants were probably the "healthiest" and the best group for detecting such a continuum, if it exists.
Comet tail length showed the strongest positive association with cancer risk among the four DNA damage parameters evaluated. The tail length parameter increases with increased density of abasic sites and strand breaks due to higher mobility of regions of DNA. That tail length was optimal for discriminating among groups suggests that a better understanding of the mechanistic significance of comet parameters and underlying biology is needed. There are few studies comparing multiple comet parameters, and most treat cells with high doses of a damaging agent such as ionizing radiation that induces uniformally distributed damage. It is not known whether the lower response of tail length versus tail moment and tail DNA to damage induced up to 4 Gy [19] is an appropriate reference for studies of endogenous damage, that is both quantitatively lower and qualitatively different due to preferential repair in transcribed regions of the genome. Our observations suggest tail length may be a sensitive indicator of low levels of inhomogeneously distributed unrepaired damage. It is appropriate to note, that of the four parameters, tail length is most subject to technical variation. Among all study groups, the three tail-related comet parameters (i.e. tail DNA, tail length, and OTM) were highly correlated. In the control, hypernormal, and breast and another cancer groups, CDM did not correlate with tail length. The correlation differences within study groups in comet parameters may indicate that the distribution of damage throughout the genome (between comet head and tail) is determined by multiple, independent processes, some operating throughout the genome, others not. Studies of the relationships between comet parameters and loss of specific DNA repair functions using cells with defined mutations of DNA repair genes would be useful.
Using post-diagnostic samples for assessing the predictive value of phenotype assays such as the Comet assay is less than ideal because assay outcome may be affected by disease status or treatment [20] . The study should be replicated with pre-diagnostic samples collected in a large prospective study. However, we found little variation in the comet assay outcome with several factors, including age, survival time (among cases), radiation treatment, and reproductive history. This is consistent with other investigations [7, 8, 21, 22] . The lymphoblastoid cell lines provided an infinite supply of cycling cells that can be used for additional assays in the future, in which damage levels are expected to reflect endogenous processes of DNA metabolism and are unlikely to reflect occupational, diet or other lifestyle variables. One cannot rule out the possibility that the transformed cells have acquired properties that may affect relevance to normal tissues.
We evaluated several factors that could have affected comet measures in systematic ways, such as cell viability, storage time, etc. We did not find evidence that these factors introduduced predictable variation in comet values. However, we did not randomly assay the lines nor did we assess "batch" effects. The closest proxy to "batch" was "cell scoring date", and we did not observe undue systematic variation over calendar time in the aggregate or by case or control groups.
In the future, studies of the level and specific nature of oxidative damage in unchallenged cells (as by Collins and colleagues [23, 24] ) would provide valuable knowledge about the variation among individuals, and contribute to development of hypotheses to test. As the environmental risk factors for these cancers are identified in case-control studies of the parent U.S. Radiologic
Technologist cohort, challenge assays that measure the formation and repair of damage from exposure to related model mutagens, such as ionizing radiation or BPDE, may be appropriate [3] .
Results of the comet assay, performed on un-challenged cells, may represent an individual's capacity to limit endogenous damage and its associated health consequences. This hypothesis is supported by several other studies in which higher background comet assay results were related to increased risk for cancer at different sites [7] [8] [9] . A corollary is that being cancer-free at advanced age might be associated with maintaining lower levels of endogenous damage. Analyses of such hyper-normal individuals have been limited generally because laboratory, clinical or hospital studies infrequently have a population base from which to select a hyper-normal group. However, enriching sample selection by various subject attributes may become more common as this design may offer gains in study power (reviewed in [25] ). The ability to explore such concepts is a strength of the large U.S. Radiologic Technologist cohort utilized in this study.
In summary, we present results that indicate increased endogenous DNA damage may increase risk for multiple cancers (that include breast cancer) and thyroid cancer. Our conclusions are strengthened by the observation that decreased endogenous DNA damage was suggestively associated with being long-lived, cancer-free, and without a history of cancer in first degree relatives. Together these results indicate a continuum of DNA damage exists and may be detected 13 by phenotypic assays. If replicated in a large prospective study, relatively simple functional assays such as this could contribute to identification of persons with increased cancer susceptibility. Early-onset (breast cancer diagnosed at age ≤ 35 years), n=38; Thyroid cancer, n=68; Hyper-normal controls (selected as long-lived, cancer-free, no cancer reported in first-degree relatives at blood collection), n=20. ‡ § ‡ ‡ ‡ ‡ ‡ ‡
